cigna glp-1 news Why is capping cost increases for pricey weight loss drugs Health insurer Cigna will stop

GLP-1s are powerful medications intended for the treatment of chronic metabolic disease not short-term cosmetic fixes

Data shows that 1.6 million adults in England, Wales, and Scotland used a GLP-1 medication for weight loss between 2024 and 2025

[42] who showed an increase of up to 45% in the Cu/Zn ratio in the case of disease with mild symptoms compared to patients with moderate symptoms, suggesting that this ratio could be a biomarker associated with exacerbation of an inflammatory process derived from the infection

Stefanski, A

These are all important factors to consider when making a decision about which treatment is right for you

Tablets travel well in tubes, weigh less than ready-to-drink bottles, and cost less per serving than pre-mixed alternatives